World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
63247
World Ranking
5885
National Ranking
3154

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Stevo Julius is affiliated with the University of Michigan-Ann Arbor in the United States. Their research predominantly falls within the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine. Additional subfields in which they have published include Endocrinology, Diabetes and Metabolism, Surgery, Public Health, Environmental and Occupational Health, as well as Pulmonary and Respiratory Medicine.

The scientist has contributed extensively to topics related to blood pressure and hypertension, with notable emphasis on hormonal regulation and hypertension, heart rate variability and autonomic control, cardiovascular function and risk factors, atrial fibrillation management and outcomes, cardiovascular health and disease prevention, and diabetes treatment and management.

Recent papers authored or co-authored by Stevo Julius include:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure, 2021, The Lancet
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death, 2021, The Lancet
  • Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis, 2021, The Lancet Oncology
  • Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes, 2022, The Lancet Diabetes & Endocrinology
  • Middle-Aged and Older Patients With Left Ventricular Hypertrophy: Higher Mortality With Drug Treated Systolic Blood Pressure Below 130 mm Hg, 2023, Hypertension

Stevo Julius frequently collaborates with several researchers, most notably Sverre E. Kjeldsen, Kristian Wachtell, Giuseppe Mancia, Maria H. Mehlum, and Peter M. Okin.

The scientist's work is often published in journals such as Journal of Hypertension, Hypertension, Blood Pressure, Exploration of Medicine, and The Lancet. Their extensive output includes 8 publications in Journal of Hypertension, 4 in Hypertension, 4 in Blood Pressure, 4 in Exploration of Medicine, and 2 in The Lancet.

Stevo Julius has been recognized as a Member of the Association of American Physicians.

Best Publications

  • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

    Lennart Hansson;Alberto Zanchetti;S George Carruthers;Björn Dahlöf

  • Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Björn Dahlöf;Richard B Devereux;Sverre E Kjeldsen;Stevo Julius

  • Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

    Stevo Julius;Sverre E Kjeldsen;Michael Weber;Hans R Brunner

  • Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Lars H Lindholm;Hans Ibsen;Björn Dahlöf;Richard B Devereux

  • Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker

    Stevo Julius;Shawna D. Nesbitt;Brent M. Egan;Michael A. Weber

  • Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study

    Kristian Wachtell;Mika Lehto;Eva Gerdts;Michael H. Olsen

  • Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.

    Michael A Weber;Stevo Julius;Sverre E Kjeldsen;Hans R Brunner

  • Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

    Peter M. Okin;Richard B. Devereux;Sverker Jern;Sverre E. Kjeldsen

  • Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study

    Kristian Wachtell;Hans Ibsen;Michael H. Olsen;Knut Borch-Johnsen

  • Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients. Losartan Intervention for Endpoint Reduction in Hypertension Study

    Hans Ibsen;Michael H. Olsen;Kristian Wachtell;Knut Borch-Johnsen

  • Mild high-renin essential hypertension. Neurogenic human hypertension?

    Murray Esler;Stevo Julius;Andrew Zweifler;Otelio Randall

  • The impact of serum uric acid on cardiovascular outcomes in the LIFE study

    Aud Høieggen;Michael H. Alderman;Sverre E. Kjeldsen;Stevo Julius

  • Heart rate and the cardiovascular risk

    Paolo Palatini;Stevo Julius

  • Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.

    Sverre E. Kjeldsen;Björn Dahlöf;Richard B. Devereux;Stevo Julius

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    Kazem Rahimi;Zeinab Bidel;Milad Nazarzadeh;Emma Copland

  • Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.

    Lars H. Lindholm;Hans Ibsen;Knut Borch-Johnsen;Michael Hecht Olsen

  • The sympathetic nervous system and the metabolic syndrome.

    Giuseppe Mancia;Pascal Bousquet;Jean Luc Elghozi;Murray Esler

  • The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.

    B Dahlöf;R Devereux;U de Faire;F Fyhrquist

  • Role of Parasympathetic Inhibition in the Hyperkinetic Type of Borderline Hypertension

    Stevo Julius;Arturo V. Pascual;Richard London

  • Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE Study

    Hans Ibsen;Kristian Wachtell;Michael H. Olsen;Knut Borch-JohnseN

Frequent Co-Authors

Sverre E. Kjeldsen
Sverre E. Kjeldsen University of Oslo
Richard B. Devereux
Richard B. Devereux Cornell University
Björn Dahlöf
Björn Dahlöf Sahlgrenska University Hospital
Markku S. Nieminen
Markku S. Nieminen University of Helsinki
Kristian Wachtell
Kristian Wachtell Cornell University
Peter M. Okin
Peter M. Okin Cornell University
Suzanne Oparil
Suzanne Oparil University of Alabama at Birmingham
Alberto Zanchetti
Alberto Zanchetti University of Milan
Paolo Palatini
Paolo Palatini University of Padua
Hans Wedel
Hans Wedel University of Gothenburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond traditional medical school, there are several online degree pathways that can open doors to rewarding careers in healthcare. Many students explore programs in nursing, medical billing, coding, or pursue advanced degrees to increase their job opportunities and earning potential.

For those interested in the administrative side of healthcare, learning about medical billing and coding certification cost can be an important step. These certifications are typically more affordable and require less time than a traditional degree.

Aspiring nurse practitioners and registered nurses can benefit from cheap np programs and by researching how much is online nursing school. There is growing demand for nurses and nurse practitioners, with flexible online options for completing both initial and advanced training.

For those looking to reach the highest level in nursing education, phd in nursing online programs offer opportunities to specialize in research, education, or leadership roles within the healthcare system. Online education makes these pathways more accessible and affordable than ever before.

Best Scientists Citing Stevo Julius

Trending Scientists

Recently Published Articles